Nevada Office of Traffic Safety discusses recent uptick in deadly crashes

March was a deadly month on Nevada's roads. We saw 25 fatalities across the state resulting a 20% increase from the same time last year.

Recommended Stories

  • Father of teen arrested with AK47 in New York subway station was killed in police shootout

    18-year-old man from Ohio with assault rifle and wearing gas mask taken into custody

  • Jeffree Star and friend Daniel Lucas involved in ‘severe’ car accident

    YouTube star’s Rolls Royce flipped three times after reportedly hitting black ice

  • UK warships to sail for Black Sea in May as Ukraine-Russia tensions rise- Sunday Times

    The deployment is aimed at showing solidarity with Ukraine and Britain's NATO allies, the newspaper reported https://bit.ly/32pc4BK. One Type 45 destroyer armed with anti-aircraft missiles and an anti-submarine Type 23 frigate will leave the Royal Navy's carrier task group in the Mediterranean and head through the Bosphorus into the Black Sea, according to the report. RAF F-35B Lightning stealth jets and Merlin submarine-hunting helicopters will stand ready on the task group's flag ship, the carrier HMS Queen Elizabeth, to support the warships in the Black Sea, the report added.

  • Latina grandmother assaulted on LA bus in anti-Asian attack

    A 70-year-old woman was getting off a bus in LA when another passenger dragged her to the other end of the vehicle and beat her, her son says

  • Biden news: President plays golf for first time in office as woman charged with threatening VP Harris

    Follow the latest updates

  • 'We Were Flying Blind': A Doctor's Account of a Woman's J&J Vaccine-Related Blood Clot Case

    An 18-year-old woman was stricken with severe headaches, vomiting, seizures, confusion and weakness in one arm early this month, strokelike symptoms that doctors at a Nevada hospital were shocked to see in someone so young. Scans found several large blood clots blocking veins that drain blood from the brain, a condition that can disable or kill a patient. Sign up for The Morning newsletter from the New York Times Doctors performed a procedure to suction huge clots from her brain, only to find that new ones had formed. The patient is one of six women ages 18 to 48 who developed clots in the brain within two weeks of receiving the Johnson & Johnson coronavirus vaccine. One died, and their devastating cases led U.S. health officials to recommend Tuesday that use of the vaccine be paused. Two more cases have been added since then: one involving a man who was vaccinated during the company’s clinical trials and another involving a woman who received the vaccine after it had been authorized for general use. As in several of the original cases, the young woman in Nevada was initially treated with heparin, a standard blood-thinner that experts have since learned may actually worsen the rare clotting disorder that has affected small numbers of people who received the Johnson & Johnson or AstraZeneca vaccines in several countries. But until the last few weeks, doctors around the world had little information about the condition, and the doctors in Nevada did not recognize it immediately. “We were flying blind, based on reports from Europe and the U.K. hematological society,” said Dr. Brian Lipman, an infectious-disease specialist who helped care for the Nevada patient at Dignity Health St. Rose Dominican Hospital, Siena Campus, in Henderson. The U.S. decision to call for suspension of the use of the vaccine was intended to give officials time to learn more about the rare disorder causing the clots, to assess whether it is linked to the vaccine and to inform doctors and patients about how to recognize symptoms and treat the condition. The pause may last until at least next Friday, when expert advisers to the Centers for Disease Control and Prevention are scheduled to meet to review the data and decide whether to resume using the vaccine. Dr. Rochelle Walensky, the director of the CDC, and other top U.S. health officials sought Friday to reassure the public that the pause, now extended more than a week, was a reasonable safeguard to assess risk. They also emphasized that overall, the Johnson & Johnson vaccine and the other vaccines in use in the United States were safe, given how many millions of Americans had gotten their shots without concern. But with the world staggered by a relentless epidemic, even temporarily stopping the use of a highly effective vaccine, which many countries had planned to deploy, is a fraught decision. Public health experts fear that the move sends a message that will erode trust globally even if the vaccine is reinstated and that huge numbers of people who could have been immunized will die needlessly from COVID-19 because they or their governments rejected the company’s vaccine. The United States, where Johnson & Johnson provided only about 5% of the COVID vaccine supply, can afford the suspension: It has plenty of other vaccine doses from Moderna and Pfizer-BioNTech to fill the gap. Other countries do not. And many nations have also stopped or limited the use of another effective vaccine, the one made by AstraZeneca, because it, too, has been linked to a similar rare clotting disorder. About 7.4 million Americans have received the Johnson & Johnson vaccine, and so far, only eight cases of the clotting problem have been reported, seven of them in women. In Europe, Britain, and three other countries, 222 cases have been reported, mostly in women under 60 — of 34 million people who have received the AstraZeneca vaccine. Several countries have now limited its use to older adults because so many cases have involved younger people. Researchers suspect that in these rare cases, the vaccine causes an intense reaction by the patient’s immune system, which churns out antibodies that activate platelets, a blood component needed for clotting. An unusual syndrome results, with extensive clotting that leaves the patient with low platelet levels and a tendency to bleed at the same time. Why this occurs in some people, many of them younger women, is not known, and experts say that they have so far been unable to identify traits or underlying conditions that may make some people susceptible. In a statement issued Wednesday, Johnson & Johnson said: “The safety and well-being of the people who use our products is our number one priority, and we strongly support awareness of the signs and symptoms of this extremely rare event to ensure the correct diagnosis, appropriate treatment and expedited reporting by health care professionals. We continue to believe in the positive benefit-risk profile of our vaccine.” The company also said, in a letter published Friday in The New England Journal of Medicine, that no causal link had been established between its vaccine and the clotting disorder. To some critics, it makes no sense to hobble a global vaccination campaign during a pandemic just because of a few cases of a rare disorder. But while rare side effects may be tolerated as the price we must pay for some drugs or vaccines, even the rarest ones are difficult to accept if they are severe and unpredictable — like blood clots in the brain, especially in young, healthy people. “This is a devastating complication,” Dr. Anthony Fauci, the chief medical adviser for the pandemic in the Biden administration, said in an interview. He added: “One woman died, three are in the hospital, one in intensive care. Even though the numbers are small, it is a devastating complication, so I believe — I didn’t make the decision — I believe their rationale, at least from what they communicated to me, is that they wanted to call a quick pause to see, to alert people. Sometimes this starts with minor symptoms, like a little abdominal discomfort, and then all of a sudden they wind up having a stroke.” He also said, “Maybe there are a lot more people out there we’re not noticing, because of the spectrum of the disease.” Informing doctors and the public of the symptoms — severe headaches, shortness of breath, leg or abdominal pain — could help identify more cases. Another reason for the pause, Fauci said, is to let doctors know that the drug heparin, a standard treatment for blood clots, should not be given to these patients, “because heparin in this circumstance can make things worse.” It is not known whether the heparin initially given to some of the patients exacerbated their condition. Experts are recommending the use of other blood thinners, which patients urgently need, because their blood clots keep growing, and new ones keep forming. Doctors in Europe who treated recipients of the AstraZeneca vaccine who had a similar condition said it could worsen rapidly. “The real issue is how long they take to make up their mind about what they’re going to do,” Fauci said of the CDC’s advisory panel. “The rest of the world is watching this, and J&J is hopefully going to be an important part of the worldwide response, as is AstraZeneca.” He added, “You don’t want to rush them, but I hope they make up their minds in a reasonable amount of time.” Another of the first six patients with the clotting condition was a healthy 48-year-old woman who went to an emergency room in Nebraska because she had felt ill with abdominal pain for three days. Her case was described in a letter to the editor of The New England Journal of Medicine published Wednesday. Her platelet count was low, and other blood tests were also abnormal. A CT scan found extensive blood clots in veins in her abdomen. She began having headaches, and another scan found clots in her brain. She was given heparin. More clots developed, and she had a hemorrhagic stroke. Doctors then learned that she had received the Johnson & Johnson vaccine two weeks before. They stopped the heparin and gave her a different blood thinner, along with intravenous immune globulin, a treatment also recommended for the clotting disorder. Her platelet count increased, but, the doctors wrote, “The patient remained critically ill at the time of this report.” The young woman in Nevada was fighting for her life and had to be placed on a ventilator, according to Lipman. He said he was speaking independently and not as a representative of the hospital. The patient’s family declined a request for an interview. Lipman said that as the team had studied her blood samples, the pieces began to fall into place, and they realized that she appeared to have the same problem that they knew had been occurring in Britain and Europe after patients received the AstraZeneca vaccine, mostly in young women. They switched from heparin to another blood thinner and began following guidance provided by doctors in Britain who had treated AstraZeneca recipients with a similar disorder. Hoping for more information about the condition and any possible connection to the Johnson & Johnson vaccine, Lipman called an emergency number at the Food and Drug Administration. It was a weekend, and he said the person who answered told him that no one was available to help and that the line had to be kept open for emergencies. “I thought this was an emergency,” Lipman said. “She hung up on me.” He called back, to ask how to reach Janssen, which makes the Johnson & Johnson vaccine. That information was not available, and he said the person who answered had also told him that the FDA could not provide advice on patient care. An FDA spokesperson, Stephanie Caccomo, said in an email, “We’ll look into this further to ensure physicians calling FDA for assistance receive the help they are seeking.” Lipman said that the pharmacist at his hospital had submitted a report online to the CDC in early April but that the agency had not contacted him to ask about the case until this week. The agency declined to comment on whether it had communicated with Lipman, a spokesperson, Kristen Nordlund, said by email. At a meeting Wednesday of a CDC advisory panel, Johnson & Johnson and Dr. Tom Shimabukuro, a safety expert at the agency, both presented data about the young woman in Nevada. After the meeting, Nevada officials issued a statement saying the meeting was the first time they had learned of a case in their state — they had previously told the public that no cases had been reported — and they were asking “federal partners” why the state had not been informed. At the Nevada hospital, an interventional radiologist passed a tube through blood vessels and on into the young woman’s brain and used a device to suction out the blood clots. More clots formed later, and he performed the procedure again. But the condition causes more than clots: The patient, like others, also had a brain hemorrhage. She was transferred to a larger hospital, where she is still on a ventilator, Lipman said. Her prognosis is uncertain, he said, adding, “Her life, not just her life, her entire family’s life, has been transformed.” This article originally appeared in The New York Times. © 2021 The New York Times Company

  • Squad members and Anti-Trump Republicans spend $70k on private security following riots

    Lawmakers spending on protection in wake of 6 January Capitol riot revealed in FEC filings

  • From Asian hate crime to a minimum wage: 25 things Ted Cruz has voted against this year

    All the votes the Texas senator opposed in 2021 – including not one confirmation of a woman to the position of Cabinet secretary

  • Every living PM outside of politics will give evidence to a new anti-corruption inquiry

    Every living Prime Minister who has quit politics will be called to give evidence in public to a major new anti-corruption lobbying inquiry to be announced on Monday. The investigation by MPs on the Public Administration and Constitutional Affairs committee (PACAC) will be the biggest and most wide ranging public ‘show trial’ into the lobbying of officials and ministers. On Saturday, William Wragg, the chairman of the committee, likened the new investigation (which will hear all evidence in public and is expected to report by the end of July) to a probe by the fictional police anti-corruption unit ‘AC-12’ on the BBC’s hit TV series Line of Duty. Mr Wragg said: "PACAC may not be the AC12 of Whitehall, nor do we envisage encountering anything quite as exciting as in a television drama. "However, it is at least a sense of duty that motivates our work, just as duty and service motivates the vast majority of those in public life. As ever, we must not let the questionable judgement of a few tarnish all." Several other inquiries have been launched into the scandal which started when it emerged that former Prime Minister David Cameron had texted government ministers in a bid to save Greensill Capital, in which he had a major financial stake, from collapse.

  • Death toll rises to four after vessel capsized in freak storm amid fears for nine men still missing

    The Seacor Power vessel capsized on Tuesday in the Gulf of Mexico during a severe storm with 19 people onboard. Nine men are still missing

  • The US has paused its use of J&J's COVID-19 shot. How will that impact vaccine equity?

    U.S. officials leaned on the one-dose J&J vaccine for hard-to-reach, vulnerable people before health officials recommended pausing its use this week.

  • Elon Musk’s SpaceX will build spacecraft to land Nasa astronauts on moon, report says

    Artemis will land the first woman and person of colour on the moon

  • Hornets’ Rozier: Don’t be ‘soft,’ but this NBA season is brutal on every player’s body

    Charlotte Hornets will be decimated by injury against the Brooklyn Nets.

  • Angels' games Saturday and Sunday postponed because of Twins' COVID issues

    MLB postponed the Angels' games scheduled for Saturday and Sunday against visiting Minnesota because of the Twins' multiple positive COVID-19 tests.

  • Zack Snyder confirms Wayne T. Carr would have played Green Lantern in his 4-hour 'Justice League' movie

    During a conversation at Justice Con 2021, Snyder confirmed that Wayne T. Carr would have played John Stewart in his "Snyder Cut."

  • Land Rover driver at Prince Philip's funeral spent week ensuring he could drive at correct speed

    The servicemen in charge of the specially modified Land Rover carrying the body of the Duke of Edinburgh spent the past week making sure they could drive “at the correct speed”. And, no wonder, as leading the vehicle on its way to the steps of St George’s Chapel, Windsor, on foot were the most senior members of the Armed Forces and the Band of the Grenadier Guards. Corporal Louis Murray was behind the wheel, with Corporal Craig French, as Land Rover Commander for the Royal Hearse, both 29 years old, alongside him. The two staff instructors from the Royal Electrical and Mechanical Engineers had been picked “on a coin-toss” from a group of four who had been training for the purpose and were described by officials as a “trusted pair of hands”. Cpl French said it was his job to “ensure that the driver puts the vehicle in the right place at the right time and whether to speed up or slow down.” “We have done a lot of practice over the last few days and you get to feel what the correct speed is, and we know what pace we have to be at. It’s now like second nature.

  • Duchess of Cambridge acts as peacemaker as Princes Harry and William share private chat

    Brought together under the saddest of circumstances, the Duke of Cambridge and the Duke of Sussex put on a show of unity at their beloved grandfather’s funeral. Reconciled for the first time in more than a year – and seen together in public for the first time since the Duke and Duchess of Sussex gave a bombshell interview to Oprah Winfrey – the estranged brothers chatted together following the 3pm ceremony at St George’s Chapel. Although they did not walk shoulder to shoulder in the procession behind the Duke of Edinburgh’s coffin, they made a point of seeking each other out after the 50-minute service and walked back to Windsor Castle side by side. It came after Prince Harry appeared to look up at his surroundings during the funeral procession, seemingly aware of the pomp and pageantry he has left behind.

  • Cassie Randolph breaks silence after ex Colton Underwood comes out as gay

    Randolph and Underwood met on season 23 of 'The Bachelor' and broke up in May 2020.

  • Times Square AK-47 Suspect Had Just Lost His Dad in a Police Shootout

    via YouTube/CBS New YorkThe father of the Ohio teen arrested Friday with an AK-47-style assault rifle in the Times Square subway station was killed in a shootout with cops last month after fleeing in his car the wrong way down a busy interstate, police sources told the New York Post and NBC News.Details about the father of Saadiq Teague have come out as questions swirl about what the 18-year-old was doing in New York City and why he was carrying a weapon. Police have so far released scant details about the young man’s plans or his possible motivation, pending further investigation.At the beginning of March, Columbus police tried to arrest Andrew Teague, Saadiq’s father, on a warrant for felonious assault. According to court documents cited at the time by local NBC affiliate WCMH, Teague was wanted over a Feb. 2 incident in which he allegedly fired more than a dozen shots at his brother.Around 3 p.m. on March 5, Columbus police officers tried to pull Teague over in his car, but he attempted to outrun them. After supervisors instructed the officers to call off the pursuit, a Columbus PD helicopter tracked Teague for more than an hour. When a sheriff’s deputy pulled up behind Teague, who was stopped, he made a U-turn and pulled onto I-287, driving against the flow of traffic at speeds up to 85 mph. A few minutes later, Teague smashed head-on into a car, careening into two other vehicles before finally coming to a stop.“My adrenaline was rushing so badly,” one of the drivers, Jeffrey Scales, told WSYX. “My first instinct was to get out of the car before it exploded...I actually couldn't get out of the front door. It peeled the side of my car back, so I had to climb out the back seat.”Scales and the people in the other two vehicles did not suffer life-threatening injuries.At that point, Teague bailed out of his own car, leading officers on a foot chase down the shoulder of the interstate. Cops said they opened fire when Teague crouched down as if he was about to start shooting at them. He was pronounced dead a short time later.A weapon was recovered at the scene that is believed to have been in Teague’s possession, Chief Deputy Jim Gilbert of the Franklin County Sheriff’s Office said at a news conference at the time.Teague was on parole at the time, a cousin told the Post, saying his parole officer had driven him “ to the edge.” “He kind of went out the only way he could,” the cousin said.Less than six weeks after Teague’s death, his teenage son would make headlines for his own run-in with the law.Saadiq Teague was arrested April 16 around 12:30 p.m. by NYPD transit officers on patrol in the Times Square subway station after spotting him with an AK-47. Cops said Teague was sitting quietly, charging his cell phone, with the rifle beside him.Although the rifle was unloaded, authorities said Teague had a fully loaded magazine in his backpack along with a gas mask they later conceded may have been part of a bong found in the teen’s hotel room. Teague reportedly told police he thought it was legal to carry an unloaded weapon in New York City if the ammunition was stored separately. Teague was visiting the city with a friend, according to police. Video posted on the young man’s Instagram page showed him strolling around the city with the AK sticking out of his backpack. Other clips appeared to show Teague and another person harassing sleeping subway riders, slapping one and throwing water on another.“This story could’ve had a tragically different ending, but thanks to these diligent cops it ends with the suspect in handcuffs,” NYPD Commissioner Dermot Shea tweeted after Saadiq Teague’s arrest.Saadiq’s story certainly had a happier ending than his father’s, who was known to family and friends as Drew.“As we reflect on Andrew and his life, you realize that every relation was one of uniqueness,” read an obituary posted on a funeral page for Andrew Teague. “He apparently had this hidden gift of making people feel that they alone filled his heart, not realizing that there were many special areas in his heart just for each one of us...Andrew was full of life and spoke excitedly about erecting family owned businesses. He spoke of mentoring and reentry programs as well as graphic art and printing. All in the name of family. Unfortunately this misfortune has taken him out the plan physically, but not out the plan itself.”An online fundraiser launched by Teague’s family to help pay for funeral expenses fell short of its $5,000 goal, collecting just $475.“We are all devastated by the loss of Drew and were not prepared for the high cost of a funeral service,” the GoFundMe campaign explained. “We want to give Drew the memorial he deserves, to honor his memory and say our last goodbyes.”Read more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.

  • Prince Philip's close friend Countess Mountbatten attends funeral on behalf of ill husband

    They became so close during the course of their nearly 30-year friendship that she was known as “and also” on account of her name always appearing on the Duke of Edinburgh’s guest list. So it was hardly a surprise when the Countess Mountbatten of Burma was included in the 30-strong congregation for Prince Philip’s funeral, handpicked by the Queen. Also known as Penny Knatchbull, later Lady Romsey and Lady Brabourne, the 68-year-old mother of three was the Duke’s carriage driving partner and one of his closest confidantes. Yet it emerged on Saturday that the Countess, pictured below, was actually representing her husband, the Earl of Mountbatten of Burma, who is unwell and therefore unable to attend.